Co-Lead for Revalidation The Royal College of OphthalmologistsMember of Professional Standards Committee, Royal College of OphthalmologistsFellow of the Royal College of OphthalmologistsMember of the Royal College of Ophthalmologists Revalidation and Quality Standards committeesRevalidation Fellow of the Royal College of Ophthalmologists 2009-2010Member of the British Medical Association

The Cataract National Dataset electronic multi-centre audit of 55,567 operations: risk indicators for monocular visual acuity outcomes. Sparrow JM, Taylor H, Qureshi K, Smith R, Birnie K, Johnston RL; UK EPR user group. Eye (Lond). 2012 Jun;26(6):821-6. doi: 10.1038/eye.2012.51. Epub 2012 Mar 23.The cataract national data set electronic multi-centre audit of 55,567 operations: case-mix adjusted surgeon’s outcomes for posterior capsule rupture. Sparrow JM, Taylor H, Qureshi K, Smith R, Johnston RL; UK EPR user groupSP Kelly, I Wallwork, D Haider, K Qureshi. Teleophthalmology with optical coherence tomography imaging in community optometry Evaluation of a quality improvement for macular patients. Clin Ophthalmol. 2011; 5:1673-8K Qureshi, S Kashani, SP Kelly. Intracameral bevacizumab for reubeotic glaucoma secondary to retinal vein occlusion. Int Ophthalmol. 2009 Dec;29 (6) 537-9KM Qureshi, S Robbie, S Kashani. Viral infections need to be excluded from the cohort for the results to be truly meaningful. Evid Based Med. 2007 Jun; 12 (3) 93SJ Robbie, K Qureshi, S Kashani, MA Qureshi. Managing conjunctivitis in general practice: research into management strategies for acute infective conjunctivitis. BMJ. 2006 Aug 26; 333 (7565) 446-7

Kashif Qureshi

BSc, MBBS, FRCOphth

Mr Qureshi is a Consultant Ophthalmic Surgeon who has a specialist interest in dealing with diseases of the retina but also manages general ophthalmic conditions, and performs cataract surgery, laser to the anterior and posterior segment, including laser to the retina and vitreous and intravitreal therapeutic procedures.

Education & Training

Mr Qureshi graduated from United Medical and Dental Schools of Guys and St Thomas’s Hospitals, London in 1999. He then worked as an Ophthalmologist for 13 years and became a fellow of the Royal College of Ophthalmologists.

He undertook sub-speciality fellowship training in diseases of the retina in the North West, at Manchester Royal Eye Hospital and then at Moorfields Eye Hospital, London.

Mr Qureshi has a specialist interest in dealing with diseases of the retina but also manages general ophthalmic conditions. He performs laser surgery to the anterior and posterior segment, including the retina and vitreous. He also performs intravitreal therapeutic procedures and cataract surgery.

Mr Qureshi has a variety of interests and profound knowledge to be able to treat disparate eye conditions that include; Cataracts, Age-related Macular Degeneration (AMD), Glaucoma and Retinal disease. This has guided his research into potential new treatment techniques moving forward.

Interests

Specialist focus on retinal diseases, including age‑related macular degeneration and other posterior segment disorders.
Research and clinical interest in diabetic eye disease / diabetic retinopathy and associated retinal complications.
Engagement with retinal vascular disorders, exploring both diagnosis and therapeutic approaches.
Investigation of novel laser treatments, including trials for dry macular degeneration using new laser technologies.
Interest in cataract surgery outcomes and techniques, reflected in multi‑centre data analysis and audits.
Research involvement in teleophthalmology and OCT imaging workflows for macular patient care improvements.
Clinical research into intracameral bevacizumab use for rubeotic glaucoma secondary to retinal vein occlusion.
Broader academic contributions include work on quality improvement and management strategies in ophthalmic practice.

Medical and surgical management of retinal diseases, including age-related macular degeneration.
Diabetic retinopathy treatment, including laser therapy and intravitreal injections.
Retinal vascular disorders, such as vein occlusions and macular edema.
Laser therapies for retinal conditions, including 2RT nanosecond laser treatment for dry AMD.
Cataract surgery, with a focus on advanced techniques and optimising visual outcomes.
Glaucoma management, including secondary glaucoma associated with retinal disease.
OCT-guided diagnosis and treatment planning for complex retinal cases.
Teleophthalmology and patient-centred care, optimising access and monitoring for chronic eye conditions.

Speciality

Mr Kashif Qureshi is a consultant ophthalmologist specialising in medical and surgical management of retinal and macular diseases, diabetic retinopathy, cataract surgery, and advanced laser therapies including innovative treatments for age-related macular degeneration.

Cataract Surgery

Cataract eye surgery is a quick, painless procedure that replaces your eye’s cloudy natural lens with a clear artificial one to restore your vision. We have performed over 30,000 successful cataract procedures, using advanced technology to gently remove the cataract and insert a new lens tailored to your lifestyle and visual needs.

Age-related Macular Degeneration

Age-related macular degeneration (AMD) is an eye condition that slowly affects the sharp, central vision needed for reading, driving, and seeing faces.

Additional Information

See below for more information relating to Mr Kashif Qureshi.

Memberships

Co-Lead for Revalidation The Royal College of Ophthalmologists
Member of Professional Standards Committee, Royal College of Ophthalmologists
Fellow of the Royal College of Ophthalmologists
Member of the Royal College of Ophthalmologists Revalidation and Quality Standards committees
Revalidation Fellow of the Royal College of Ophthalmologists 2009-2010
Member of the British Medical Association

Affiliated Insurance Companies

Centre for Sight is recognised by a number of private medical insurance companies and Mr Kashif Qureshi is a registered provider to:

Aviva
AXA
Bupa
Cigna
Exeter Friendly (Part of AXA)
Healix
Pru Health
WPA

Publications

The Cataract National Dataset electronic multi-centre audit of 55,567 operations: risk indicators for monocular visual acuity outcomes. Sparrow JM, Taylor H, Qureshi K, Smith R, Birnie K, Johnston RL; UK EPR user group. Eye (Lond). 2012 Jun;26(6):821-6. doi: 10.1038/eye.2012.51. Epub 2012 Mar 23.
The cataract national data set electronic multi-centre audit of 55,567 operations: case-mix adjusted surgeon’s outcomes for posterior capsule rupture. Sparrow JM, Taylor H, Qureshi K, Smith R, Johnston RL; UK EPR user group
SP Kelly, I Wallwork, D Haider, K Qureshi. Teleophthalmology with optical coherence tomography imaging in community optometry Evaluation of a quality improvement for macular patients. Clin Ophthalmol. 2011; 5:1673-8
K Qureshi, S Kashani, SP Kelly. Intracameral bevacizumab for reubeotic glaucoma secondary to retinal vein occlusion. Int Ophthalmol. 2009 Dec;29 (6) 537-9
KM Qureshi, S Robbie, S Kashani. Viral infections need to be excluded from the cohort for the results to be truly meaningful. Evid Based Med. 2007 Jun; 12 (3) 93
SJ Robbie, K Qureshi, S Kashani, MA Qureshi. Managing conjunctivitis in general practice: research into management strategies for acute infective conjunctivitis. BMJ. 2006 Aug 26; 333 (7565) 446-7